International Publisher of Science, Technology and Medicine

 
 
Share this
 
 
 
Track Your Manuscript
 
 
 
 
Cell Biology: Research & Therapy
Editor-in-chief: Paul J. Higgins, PhD
Albany Medical College, USA
ISSN: 2324-9293
Frequency: Quarterly
Mode of Publication: Hybrid (Open Access & Subscription)
Peer Reviewed Journal
The journal Cell Biology: Research & Therapy (CBRT) promotes rigorous research that makes a significant contribution in advancing and propagating knowledge in the field of cell and molecular biology. Cell Biology is a scientific discipline which involves study of the basic unit of life, cell. Research work under the domain revolves around the study of cell organelles, physiology, cell-cell interactions, molecular biochemistry, genetics, cell death and reproduction etc.

Cell Biology: Research & Therapy is a hybrid, peer reviewed, scholarly journal that provides a dual mode of publication; open access & subscription, thus facilitates wider reachability and visibility of the published work and a range of options to purchase our articles and also permits unlimited Internet Access to complete Journal content. It accepts research, review papers, online letters to the editors & brief comments on previously published articles or other relevant findings in SciTechnol. Articles submitted by authors are evaluated by a group of peer review experts in the field and ensures that the published articles are of high quality, reflect solid scholarship in their fields, and that the information they contain is accurate and reliable.

Scope and Relevance of the Journal:

  • Cell Anatomy 
  • Cell Physiology
  • Cell Signalling & Transduction
  • Cell Differentiation
  • Molecular Biology
  • Immunology
  • Genetics
  • Biochemistry
  • Stem Cell Biology: Research & Application
  • Application of Bioinformatics, Proteomics & Computational Biology in Cell Science

The journal uses Editorial Manager System for quality in review process. Editorial Manager is an online manuscript submission, review and tracking system. Review processing is performed by the editorial board members of Cell Biology: Research & Therapy journal or experts from outside. Minimum two independent reviewer’s approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system. Reviewers can download manuscripts and submit their opinions to the editor whereas editors can manage the whole submission/review/revise/publish process via editorial manager. 

Submit manuscript at http://www.editorialmanager.com/scitechnol/ or send as an e-mail attachment to the Editorial Office at editor.cbrt@scitechnol.com or editor.cbrt@scitechnol.org  

Cell Biology: Research & Therapy is organizing & supporting 4th World Congress on Cell Science & Stem Cell Research, on June 24-26, 2014 Valencia, Spain with the theme, "To Explore & Exploit Cell Science and Stem Cell Research".

 
Current Issue
Distribution of Characteristic Mutations in Native Ductal Adenocarcinoma of the Pancreas and Pancreatic Cancer Cell Lines   Research Article
Wagenhäuser MU, Rückert F, Niedergethmann M, Grützmann R, and Saeger HD
Cell Biol: Res Ther 2013, 2:2    doi: 10.4172/2324-9293.1000104
 Preview

Distribution of Characteristic Mutations in Native Ductal Adenocarcinoma of the Pancreas and Pancreatic Cancer Cell Lines

Although oncological treatment of pancreatic adenocarcinoma (PDAC) has improved within the last few years, PDAC continues to have a very low 5- year survival rate. Basic research is needed to improve and develop new therapeutic strategies. Pancreatic tumour cell lines (CLs) are a prerequisite for such basic research. However, the isolation of CLs is challenging. Outgrowth of cells is only achieved in a small proportion of tumour samples, although the reason for this poor growth remains unknown.

|  Full Text |   PDF   
Chemotherapy Increases Aggressiveness of Prostate Cancer via Epithelial Mesenchymal Transition   Short Communication
John J Kim, James E Verdone and Steven M Mooney
Cell Biol: Res Ther 2013, 2:2    doi: 10.4172/2324-9293.1000105
 Preview

Chemotherapy Increases Aggressiveness of Prostate Cancer via Epithelial Mesenchymal Transition

Although chemotherapy has been used as a major therapeutic weapon against advanced prostate cancer, overcoming drug resistance is still a major challenge. Cancer has been known to diminish therapeutic effect by several molecular mechanisms– increasing efflux by recruiting cell membrane pumps and limiting drug diffusion by constructing leaky vasculature. Moreover, recent studies suggest that long-term treatment with chemotherapy may have detrimental effects for patients presenting with solid tumors. Specifically, prostate cancer epithelial cells develop resistance to chemotherapy and may convert into mesenchymal cells. This switching process, known as Epithelial to Mesenchymal Transition (EMT), is a critical precursor in prostate cancer invasion and metastasis.

|  Full Text |   PDF   
NGF and APP Interplay: Focus on YENPTY Motif of Amyloid Precursor Protein and Y682 Residue   Review Article
Basso E and Matrone C
Cell Biol: Res Ther 2013, 2:2    doi: 10.4172/2324-9293.1000106
 Preview

NGF and APP Interplay: Focus on YENPTY Motif of Amyloid Precursor Protein and Y682 Residue

Cholinergic deficits originated from NGF metabolism disruption, represent one of the early changes in Alzheimer’s disease, where abnormal deposition of β-amyloid peptide (Aβ) and phosphorylated Tau define the neuropathological hallmarks of the disorder. A failure in NGF maturation can promote pro-apoptotic pathway activation, through p75 receptor; while lack of NGF signalling can generate an atypical TrkA receptor phosphorylation resulting in neuronal cell death and Aβ toxicity. These evidences suggest a complex interaction between TrkA, p75, and Aβ, whose exact cellular mechanisms remain still elusive. Here, we provide a general overview on the current knowledge on NGF and APP interplay, focusing on the events that mediate NGF signalling impairment, and, mostly, on the role of APP Tyrosine 682 phosphorylation whose absence in APPY682G mice impairs APP/TrkA interaction and leads to cholinergicneurodegeneration.

|  Full Text |   PDF   
The Human Skeletal System and Spaceflight Analogs   Review Article
Mamta Patel Nagaraja
Cell Biol: Res Ther 2013, 2:2    doi: 10.4172/2324-9293.1000107
 Preview

The Human Skeletal System and Spaceflight Analogs

The human skeletal system is a dynamic system that plays vital roles in the sustenance of life. Bone loss is a phenomenon that occurs in humans both in short and in long term spaceflights. The phenotype can be also reproduced on the ground in human and animals and also modeled in cell-based analogs. With limited missions in space, experimental studies in these analogs have provided much of our understanding of bone loss.

|  Full Text |   PDF